VioQuest Pharmaceuticals Expands Global Operations in China

VioQuest Pharmaceuticals completed construction of its new pilot production facility in Jiashan, China. This modern, American-standard laboratory provides the capacity to quickly scale-up chiral building blocks and catalysts production to meet the growing customer demand. Additionally, it provides cost-effective access to China's research and development talent. Four floors totaling 40,000 square feet located just outside of Shanghai, have been outfitted to produce up to 100 kilos of efficient, economical, chiral building blocks and catalysts.

()a href="http://www.biotecheast.com/modules.php?op=modload&name=News&file=article&sid=921&topic=2" target="_blank">Biotech East